Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.82  0.02  0.70%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  

Lisata Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Lisata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a minute ago at businesswire.com         
Vernal Biosciences Appoints Jim Petrilla as CEO Board Director
businesswire News
22 hours ago at simplywall.st         
Swelling losses havent held back gains for LigaChem Biosciences shareholders since theyre up 256 per...
Simply Wall St News at Macroaxis
a day ago at seekingalpha.com         
Neurogene and Ventyx Biosciences rises after insider buying by executives
seekingalpha News
a day ago at investing.com         
Aptose Biosciences CEO William Rice acquires 20,000 in shares
Investing News at Macroaxis
2 days ago at gurufocus.com         
Forte Biosciences to Host RD Day December 3, 2024
Gurufocus Stories at Macroaxis
2 days ago at gurufocus.com         
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, ...
Gurufocus Stories at Macroaxis
2 days ago at globenewswire.com         
Aptose Biosciences Inc. Announces Closing of 8 Million Public Offering
Macroaxis News: globenewswire.com
2 days ago at investing.com         
Enveric Biosciences faces potential Nasdaq delisting
Investing News at Macroaxis
few days ago at gurufocus.com         
Insider Buying Forte Biosciences Inc CFO Antony Riley Acquires Additional Shares
Gurufocus Stories at Macroaxis
few days ago at thelincolnianonline.com         
Aptose Biosciences Hits New 1-Year Low Heres What Happened
news
few days ago at seekingalpha.com         
Anixa Biosciences board approves purchase of Bitcoin as treasury reserve asset
seekingalpha News
few days ago at gurufocus.com         
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Aptose Biosciences Inc. Announces Pricing of 8 Million Public Offering
Yahoo News
few days ago at gurufocus.com         
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
The Dr. James Morales Grant for Medicine and Biosciences Invites Undergraduate Scholars to Apply
Yahoo News
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Castle Biosciences Inc Trading 3.24 percent Higher on Oct 29
10/29/2024
2
Cytek Biosciences, Inc. Q3 Earnings and Revenues Beat Estimates
11/05/2024
3
Artelo Biosciences Stock Dips Amidst Financial Report
11/13/2024
4
Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
11/18/2024
5
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinsons Research Through Development of Next Generation Biomarker As...
11/19/2024
6
Forte Biosciences, Inc. Announces Oversubscribed 53 Million Private Placement From Leading ...
11/20/2024
7
The Dr. James Morales Grant for Medicine and Biosciences Invites Undergraduate Scholars to Apply
11/21/2024
8
Anixa Biosciences board approves purchase of Bitcoin as treasury reserve asset
11/22/2024
9
Aptose Biosciences Inc. Announces Closing of 8 Million Public Offering
11/25/2024

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance